The Inflammation Study
The purpose of this study is to test a potential new treatment for Cystic fibrosis (CF)
The Inflammation Study is testing a new drug that may help treat Cystic Fibrosis (CF), a serious genetic disease that affects the lungs and pancreas. CF causes thick, sticky mucus to build up in the lungs, making it hard to breathe and leading to frequent infections.
This study aims to evaluate the potential of the new drug to improve symptoms and help manage the disease, which currently affects over 3,600 people in Australia. By participating, you can contribute towards the development of a new treatment which could be more effective for the treatment of CF.
Clinical Trial Details:
- An independent ethics committee has approved this clinical trial.
- Participants will be reimbursed for their time
Call us on 1800 243 733 to discuss your eligibility today!